ACRS | | Aclaris Therapeutics, Inc. | Ruffo Frank | Chief Financial Officer | Mar 10, 2022 | Sale | $15.55 | 12,823 | 199,335 | 201,883 | Mar 14, 2022, 04:56 PM |
ACRS | | Aclaris Therapeutics, Inc. | Ruffo Frank | Chief Financial Officer | Feb 09, 2022 | Sale | $12.66 | 1,388 | 17,568 | 172,359 | Feb 11, 2022, 04:18 PM |
ACRS | | Aclaris Therapeutics, Inc. | Ruffo Frank | Chief Financial Officer | Jun 02, 2021 | Sale | $21.64 | 15,037 | 325,383 | 172,322 | Jun 02, 2021, 09:43 PM |
ACRS | | Aclaris Therapeutics, Inc. | Ruffo Frank | Chief Financial Officer | Apr 26, 2021 | Sale | $25.80 | 27,339 | 705,228 | 151,820 | Apr 26, 2021, 09:45 PM |
ACRS | | Aclaris Therapeutics, Inc. | Ruffo Frank | Chief Financial Officer | Apr 22, 2021 | Sale | $26.84 | 30,000 | 805,218 | 209,059 | Apr 26, 2021, 09:45 PM |
ACRS | | Aclaris Therapeutics, Inc. | Ruffo Frank | Chief Financial Officer | Apr 23, 2021 | Sale | $26.66 | 30,000 | 799,660 | 179,859 | Apr 26, 2021, 09:45 PM |
ACRS | | Aclaris Therapeutics, Inc. | Ruffo Frank | Chief Financial Officer | Mar 01, 2021 | Option Exercise | $24.06 | 7,333 | 176,432 | 233,606 | Mar 03, 2021, 08:36 PM |
ACRS | | Aclaris Therapeutics, Inc. | Ruffo Frank | Chief Financial Officer | Mar 02, 2021 | Option Exercise | $23.25 | 2,844 | 66,123 | 239,059 | Mar 03, 2021, 08:36 PM |
ACRS | | Aclaris Therapeutics, Inc. | Ruffo Frank | Chief Financial Officer | Feb 01, 2021 | Option Exercise | $21.35 | 1,308 | 27,926 | 215,189 | Feb 03, 2021, 05:29 PM |
ACRS | | Aclaris Therapeutics, Inc. | Ruffo Frank | Chief Financial Officer | Dec 15, 2020 | Option Exercise | $4.59 | 370 | 1,698 | 212,622 | Dec 17, 2020, 05:07 PM |
ACRS | | Aclaris Therapeutics, Inc. | Ruffo Frank | Chief Financial Officer | Jun 01, 2020 | Option Exercise | $1.32 | 9,451 | 12,475 | 211,692 | Jun 03, 2020, 04:45 PM |
ACRS | | Aclaris Therapeutics, Inc. | Ruffo Frank | Chief Financial Officer | Mar 02, 2020 | Option Exercise | $1.26 | 7,162 | 9,024 | 187,955 | Mar 04, 2020, 04:30 PM |
ACRS | | Aclaris Therapeutics, Inc. | Ruffo Frank | Chief Financial Officer | Feb 03, 2020 | Option Exercise | $1.28 | 1,308 | 1,674 | 169,367 | Feb 04, 2020, 07:12 PM |
ACRS | | Aclaris Therapeutics, Inc. | Ruffo Frank | Chief Financial Officer | Dec 18, 2019 | Option Exercise | $1.81 | 356 | 644 | 166,800 | Dec 20, 2019, 04:18 PM |
ACRS | | Aclaris Therapeutics, Inc. | Ruffo Frank | Chief Financial Officer | Dec 16, 2019 | Option Exercise | $1.80 | 370 | 666 | 165,906 | Dec 18, 2019, 11:02 AM |
ACRS | | Aclaris Therapeutics, Inc. | Ruffo Frank | Chief Financial Officer | Feb 01, 2019 | Option Exercise | $6.96 | 1,308 | 9,104 | 164,976 | Feb 05, 2019, 06:31 PM |
ACRS | | Aclaris Therapeutics, Inc. | Ruffo Frank | Chief Financial Officer | Dec 18, 2018 | Option Exercise | $6.30 | 356 | 2,243 | 162,409 | Dec 21, 2018, 07:34 AM |
ACRS | | Aclaris Therapeutics, Inc. | Ruffo Frank | Chief Financial Officer | Dec 15, 2018 | Option Exercise | $7.31 | 370 | 2,705 | 161,515 | Dec 18, 2018, 08:54 PM |
ACRS | | Aclaris Therapeutics, Inc. | Ruffo Frank | Chief Financial Officer | May 07, 2018 | Option Exercise | $18.10 | 1,480 | 26,788 | 160,585 | May 09, 2018, 04:20 PM |
ACRS | | Aclaris Therapeutics, Inc. | Ruffo Frank | Chief Financial Officer | May 07, 2018 | Buy | $18.22 | 1,250 | 22,775 | 156,865 | May 07, 2018, 04:28 PM |
ACRS | | Aclaris Therapeutics, Inc. | Ruffo Frank | Chief Financial Officer | Apr 06, 2018 | Buy | $16.59 | 1,250 | 20,738 | 155,615 | Apr 09, 2018, 04:51 PM |
ACRS | | Aclaris Therapeutics, Inc. | Ruffo Frank | Chief Financial Officer | Dec 15, 2017 | Option Exercise | $24.23 | 395 | 9,571 | 144,477 | Dec 21, 2017, 04:57 PM |
ACRS | | Aclaris Therapeutics, Inc. | Ruffo Frank | Chief Financial Officer | Dec 18, 2017 | Option Exercise | $24.12 | 380 | 9,166 | 145,347 | Dec 21, 2017, 04:57 PM |
ACRS | | Aclaris Therapeutics, Inc. | Ruffo Frank | Chief Financial Officer | Dec 18, 2016 | Option Exercise | $31.25 | 380 | 11,875 | 143,572 | Dec 20, 2016, 06:51 PM |